Invesco Ltd.
NYSE:IVZAsset Management
-$0.41 today
- Market cap
- $12.59B
- Beta
- 1.59
- P/E (TTM)
- -53.4
- EPS (TTM)
- -$0.54
- Dividend yield
- 2.94%
Volume 5.54M
Average 5.41M
IVZ Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Invesco Ltd.NYSE: IVZ
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 38.6% from a year ago
Cash & equivalents stood at $915.4M at the end of Q2 FY2026, down 38.6% from a year earlier and up 13.4% from the prior quarter. Over 3 fiscal years it compounded at +11.3% a year.
Context
- Cash & equivalents amounted to 3.3% of total assets at the end of Q2 FY2026, down 1.9 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -38.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 1.98B USD
- Year-over-year change
- +32.3%
- 4-year CAGR
- -2.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.98B | +32.3% |
| FY2024 | 2024-12-31 | 1.5B | -22.6% |
| FY2023 | 2023-12-31 | 1.93B | +34.7% |
| FY2022 | 2022-12-31 | 1.43B | -33.2% |
| FY2021 | 2021-12-31 | 2.15B | — |
Cash & Equivalents vs competitors
How IVZ compares with its peers on the latest reported figures
- IVZ's Jun 2026 cash & equivalents of $915.4M is the 5th highest of the 11 companies compared; the peer median is $417.93M.
- Its year-over-year change of -38.6% is the 9th highest of 10, against a peer median of +5.7%.
- Cash & equivalents amounts to 3.3% of total assets for IVZ, versus a peer median of 10.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $10.25B | +22.3% | +12.5% | 5.2% | |
| Jun 2026 | $5.26B | +43.7% | -3.0% | 1.5% | |
| Jun 2026 | $3.23B | +5.7% | +24.4% | 21.1% | |
| Sep 2026 | $3.23B | -9.7% | -9.8% | 8.4% | |
| Jun 2026 | $915.4M | -38.6% | +11.3% | 3.3% | |
| Sep 2026 | $436.1M | -8.4% | +10.9% | 4.5% | |
| Sep 2026 | $399.77M | -49.6% | -22.3% | 11.6% | |
| Sep 2026 | $352.4M | +3.0% | +21.3% | 23.3% | |
| Mar 2026 | $73.06M | +8.1% | +7.4% | 45.5% | |
| Mar 2026 | $23.41M | +148.6% | +3.2% | 15.6% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding IVZ) | $417.93M | +5.7% | +7.4% | 10.0% | |
Competitors are the stored peer set for IVZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.15B | 1.43B | 1.93B | 1.5B | 1.98B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.32B | 1.01B | 701.5M | 1.11B | 8.79B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | (166M) | 0 | 250.1M | 0 | 0 |
| Total Current Assets | 3.46B | 2.44B | 2.88B | 2.61B | 10.77B |
| Property, Plant & Equipment (Net) | 518.1M | 561.1M | 599.5M | 479M | 378.9M |
| Goodwill | 8.88B | 8.56B | 8.69B | 8.32B | 8.48B |
| Intangible Assets | 7.23B | 7.14B | 5.85B | 5.75B | 3.93B |
| Long-term Investments | 9.97B | 2.66B | 9.22B | 2.5B | 2.68B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.62B | 8.4B | 1.69B | 7.35B | 861.7M |
| Total Non-current Assets | 29.22B | 27.32B | 26.05B | 24.4B | 16.33B |
| Total Assets | 32.69B | 29.76B | 28.93B | 27.01B | 27.09B |
| Account Payables | 39.2M | 59.6M | 31.5M | 30.6M | 20.4M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 80.6M | 89.1M | 110.5M | 146M | 100.1M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 1.41B | 0 | 0 |
| Total Current Liabilities | 2.76B | 1.5B | 2.27B | 830.4M | 897M |
| Long-term Debt | 9.42B | 8.08B | 8.61B | 7.09B | 9.38B |
| Deferred Tax Liabilities | 1.63B | 1.66B | 1.33B | 1.28B | 901.5M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.91B | 1.19B | 372.7M | 1.68B | 2.51B |
| Total Non-current Liabilities | 13.25B | 11.41B | 10.74B | 10.51B | 13.19B |
| Total Liabilities | 16.01B | 12.91B | 13.02B | 11.34B | 14.09B |
| Common Stock | 113.2M | 113.2M | 113.2M | 113.2M | 113.2M |
| Retained Earnings | 7.17B | 7.52B | 6.83B | 6.99B | 5.89B |
| Accumulated OCI | (441.5M) | (942.4M) | (801.8M) | (1.04B) | (722.9M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.18B | 1.63B | 1.32B | 1.11B | 773.9M |
| Total Equity | 16.68B | 16.84B | 15.92B | 15.67B | 13B |
| Total Debt | 9.71B | 8.56B | 9.05B | 7.55B | 9.78B |
| Net Debt | 7.56B | 7.12B | 7.11B | 6.05B | 7.8B |
Invesco Ltd.
NYSE:IVZ
Intrinsic Alpha fair value
Locked
Current Price
$28.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.